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ESCHEmCHIA COLI endotoxin (LPS) when infused through
the renal artery of the rabbit isolated perfused kidney
prepared as constant pressure mode, caused a decrease in
flow rate and kidney weight indicating its primary
vasoconstrictor effect. This effect was predominant in
kidneys from rabbits pretreated with LPS. EndotheHn-1 at
a concentration of 10-lM and big endothelin-1 at a con-
centration of 10-8M produced equal vasoconstrictor ef-
fects in kidney. Addition of endotheHn converting en-
zyme inhibitor, phosphoramidon, to the perfusion me-
dium at a concentration of 10-6M caused a reduction in
the effects of both LPS and big ET-1 without altering the
vasoconstrictor effect of ETol. However, addition of
methylene blue (10-3 M), a soluble guanylate cyclase in-
hibitor and NG-nitro-L-arginine-methyl ester (10-6 M) to
the perfusion medium caused a potentiation in the
vasoconstrictor effect of LPS. Indomethacin at a concen-
tration of 10-6M did not alter the effect of LPS. These
results were taken as evidence for the participation of
endothelin peptides and the L-arginine-nitric oxide path-
way in the effect ofLPS in rabbit isolated perfused kidney.
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Introduction
Bacterial endotoxin is known to cause damage in
endothelial cells altering the structure, metabolism
and permeability. Peripheral vascular failure, in re-
sponse to catecholamines and other vasoconstrictors,
is the major factor causing death in human septic
shock and endotoxin injected animals. 2,3 Recently No-
nitro-L-arginine-methyl ester (t-NAME) an inhibitor of
nitric oxide (NO) synthase, was shown to reduce
hypotension induced by endotoxin (Escherichia coli
lipopolysaccharide, LPS) and restore the pressor
effects of noradrenaline (NA) and other vasocon-
strictors.4,5 These observations indicate that one of
the mechanisms of vascular hyporeactivity induced
by LPS is the increased production of NO from L-
arginine (L-Arg) in blood vessels by activation of NO
synthase. This hypothesis was supported by the
study of Knowles et al. who showed that LPS acti-
vates the production of NO in the rat aorta. Two
distinct isoforms of NO synthase have been de-
scribed. One is the constitutive Cai//calmodulin
dependent form which is mainly localized in
endothelial cells; the other, however, is an inducible
Ca2//calmodulin independent enzyme which pre-
dominates in vascular smooth muscle cells.
Infusion of LPS was shown to increase blood
pressure associated with an increase of endothelin-
1 (ET-1) levels in rat serum. Furthermore, LPS can
stimulate the release of ET-1 from cultured bovine
aortic endothelial cells. It has been shown that
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plasma and pulmonary lymph levels of ET-1 increase
significantly during endotoxic shock.1
These results indicate that LPS causes the release
or overproduction of endothelium derived vasoac-
tive substances. The data presented in this paper give
evidence of the release of NO and ET peptides by
LPS in the rabbit isolated perfused kidney.
Material and Methods
Experiments were performed on isolated perfused
kidneys from adult rabbits of both sexes weighing
2.5-3.0 kg. Either LPS (5 mg/kg) or saline (1 ml as
control) was injected i.p. and 4 h later rabbits were
anaesthetized with sodium thiopental (20 mg/kg i.v.)
and then premedicated with sodium heparin (500 IU/
kg i.v.). Both kidneys were removed after cannula-
tion of the renal arteries with appropriate polyethy-
lene tubing as described previously.
11,2 The ureter
was cut at its upper part near to the pelvis renalis to
eliminate any resistance during urine discharge. The
renal vein was also cut and venous return was
discarded. Perfusion medium was Krebs-Hanseleit
solution with the following composition: (mM) Na/,
138.2; K/, 5; Ca2+, 2.5; Mg2+, 0.5; el-, 123; HCO, 25;
H2PO, 1.2; dextrose, 11.5; gassed with 95% 02 + 5%
CO2 mixture, giving pH 7.4 at 37C. Perfusion
was provided in constant pressure mode at
80-100 mmH20. Flow changes were evaluated by
means of the pressure drop at the T tube (Venturi
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Tube) connection and correlated with the response
of a pressure transducer (Statham P23 XL). Organ
weight was also measured simultaneously through-
out the experiment by means of a force displacement
transducer (Grass FT.03). At a constant pressure
mode (80-100 mmH20) the basal flow was measured
and recorded as the maximal flow rate, which was
estimated as 5.0-8.0 ml/min. Zero flow rate was re-
corded by intermission of circuit. Thus, changes in
flow rate were evaluated at this range for individual
experiments.
All chemicals used in this study were dissolved in
saline. E. coli B-lipopolysaccharide endotoxin (lot
number 055:35, Difco Lab., Detroit, MI, USA) was
prepared at a concentration of 1% before use. Stock
solutions of porcine ET-1 and big ET-1 (Sigma)
(10-5 M) were kept frozen at-20C. Further dilutions
were made in Krebs solution just before use and
were infused through the renal artery at the same
flow rate (0.1 ml/min). A stock solution (10-2 M) of
Phos (Sigma), an endothelin converting enzyme in-
hibitor, 13,14 was also kept frozen at -20C. Further
dilution was made in Krebs buffer. Methylene blue
(MeB), a soluble guanylate cyclase inhibitor15 and L-
NAME (Sigma), a NO synthase inhibitor,4,5 were
freshly prepared in saline and added to the incuba-
tion buffer for individual experiments. Indomethacin
(IND, Sigma) was dissolved in absolute ethanol and
further dilutions were made in saline just before use.
Following the control measurements of LPS and
ET peptides, Phos (10-6 M), MeB (10-5 M), t-NAME
(10-6 M) and IND (10-6 M) were added to the incuba-
tion medium and kidneys were allowed to perfuse
for at least 20-30 min. The tests were repeated in a
separate series of experiments.
All data were expressed as the arithmetic
mean _+ S.E.M. The statistical significance of differ-
ences from the control was estimated using paired
Student’s t-test, p values less than 0.05 were consid-
ered significant.
Results
The maximal flow rate of Krebs perfused kidneys
with constant pressure mode (80 mmHiO) from LPS
pretreated rabbits was calculated as 8.7 +_ 0.9 ml/min
in a series of experiments (n 15). Infusion of LPS
into the renal artery for 2 min (total 100 g) produced
a decrease in flow and kidney weight indicating its
predominant vasoconstrictor effect as shown in the
first parts of Figs 1 and 2. The response in both
parameters reached the maximal level within
4.0 _+ 1.0 (n 15) min in kidneys from LPS pretreated
rabbits but more than 20 min in kidneys from intact
animals. Addition of MeB to the incubation medium
at the concentration of 10-5 M caused a potentiation
in both parameters as shown in the second part of
Fig. 1. Similar potentiated responses in both para-
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FIG. 1. A typical recorder tracing of the isolated perfused kidney from LPS
pretreated rabbit showing the effect of LPS infusion on flow rate (F) and
kidney weight (W) before and after addition of methylene blue (MeB) into
the perfusion medium. Response to LPS increased significantly after MeB.
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FIG. 2. A recorder tracing of the isolated perfused kidney with constant
pressure mode from LPS treated rabbit representing the effect of LPS
infusion for 2 min before and after phosphoramidon (Phos). Upper part
indicates flow rate (F), lower part shows kidney weight (W). Response to
LPS infusion for 2 min (total amount 100 l.tg) markedly decreased after
Phos.
meters against LPS were obtained when kidneys
were pretreated with t-NAME. The calculated results
of a series of experiments are shown in Table 1,
indicating a highly significant difference (p < 0.01) in
both parameters when compared with their corre-
sponding controls. In another series of experiments,Release ofNO and ETpeptidesfrom kidney by LPS
Table 1. Decrease in flow rate and kidney weight by LPS and
changes induced by MeB, L-NAME and Phos
Compound Decrease in flow Number Decrease in
added rate (/ ml) of kidney weight
experiments (A mg)
(n)
Control LPS 1.83 + 0.25 15 310.0 + 22.0*
MeB + LPS 3.40 + 0.40 15 418.0 + 32.0**
Control LPS 2.45 + 0.70 15 375.0 + 34.0*
Control LPS 1.76 + 0.93 7 305.0 + 43.2*
L-NAME + LPS 4.71. + 0.73 7 395.0 + 53.6**
Phos + LPS 0.75 + 0.12 15 93.0 + 11.5**
*,** p < 0.01 when compared with their corresponding controls.
Amount of each compound used was: LPS, 100 mg; MeB, 10-s M;
L-NAME, 10-6 M; Phos, 10-6 M.
Values are the mean + S.E.M.
Table 2. Decrease in flow rate and kidney weight by ET-1 and big
ET-1 and changes induced by Phos
Compound Decrease in flow Decrease in kidney
added rate (/ ml) weight (/ mg)
ET-1 5.80 + 1.3 420.0 + 41.5
Big ET-1 4.67 + 2.3 388.0 + 28.6*
Phos + ET-1 6.70 + 2.6 440.0 + 55.0
Phos + big ET-1 1.70 + 0.9 120.0+ 21.6**
*,** p< 0.01 when compared with their corresponding controls.
Amount of each compound used was: ET-1, 10-l M; big ET-1,
10-8 M; Phos 10-6 M.
Values are the mean + S.E.M.
Phos, added to the perfusion medium at the concen-
tration of 10-6 M, inhibited the effects of LPS signifi-
cantly (p < 0.01) in perfusion flow and kidney weight
as shown in Fig. 2 (second part) and Table 1. Phos
also reduced the effect of big ET-1 without altering
the effect of ET-1 in both parameters. The calculated
results are shown in Table 2. No appreciable change
was observed in both parameters against LPS and
ET-1 when the experiments were repeated in the
presence of IND (10-6 M).
Discussion
The results of this study indicate that both NO and
ET peptides play an important role in the mediation
of responses caused by LPS in the rabbit isolated
perfused kidney. Changes in renal flow and organ
weight under constant pressure mode of perfusion
system are two sensitive and reproducible para-
meters for the evaluation of vasoactive substances in
isolated perfused kidney. According to the results of
the present study LPS caused a decrease in renal flow
and kidney weight, indicating its main vasocon-
strictor effect when infused into the renal artery of
the rabbit isolated perfused kidney. Other vasocon-
strictors such as noradrenaline and angiotensin II
also elicit a decrease in flow rate and kidney weight
when injected into the renal artery (data not shown).
ET-1 and big ET-1 caused similar vasoconstrictor
response as measured by both parameters when
directly infused into the renal artery. The
vasoconstrictor effect of LPS attenuated significantly
after the treatment of kidney with Phos, a known
metallopeptidase inhibitor which inhibits the conver-
sion of big ET-1 to ET-116 indicating the primary role
of ET peptides in the mechanism of LPS induced
vasoconstriction. It is well known that endothelial
cells of the resistance vessels of kidney produce ET
peptides.
17 The vasoconstrictor response to LPS is a
rapid phenomenon in the kidneys from LPS
pretreated animals when compared with the re-
sponse observed in untreated kidneys, indicating a
predisposing and promoting action of LPS on the
cascade production of ET peptides in kidney.
The results of the present study also indicate that
the production of NO in resistance vessels of kidney
can contribute to the effect of LPS. The effect of LPS
is prominent on kidney vasculature in LPS treated
animals, supporting the results of Schneider et al. 18
who showed an elevation of L-arg derived NO in
small mesenteric arteries from endotoxin treated rats.
It has been reported that LPS induced NO synthase
activity in cultured endothelial cells19 and endog-
enous L-arg is sufficient for maximal NO production
by the calmodulin activated constitutive NO synthase
in endothelial cells.2 It has been shown previously
that acetylcholine produces vasodilatation in the iso-
lated perfused rabbit kidney when submaximal
vasoconstriction is elicited by phenylephrine.
12 Re-
moval of endothelium by Triton X-10021 or pretreat-
ment of kidney with MeB, a soluble guanylate
cyclase inhibitor, 15 completely abolished the vaso-
dilator effect of acetylcholine, indicating that this
response is mediated by the release of EDRF (NO)
from the resistance vessels of kidney.
12 In the present
study, prior treatment of kidney with MeB greatly
enhanced the vasoconstrictor effect of LPS as evi-
denced by the significant decrease of flow rate and
kidney weight. Specific NO synthase inhibitor t-
NAME also produced similar potentiation as ob-
served with MeB.indicating the role of t-arg-NO
pathway on the effect of LPS in rabbit isolated
perfused kidney. IND did not alter the effect of LPS
in kidney, indicating lack of participation of pros-
tanoids in rabbit isolated perfused kidney.
All these results strongly indicate that LPS causes
an increase in the production of both NO and ET
peptides in the isolated perfused kidney from rabbits
pretreated with LPS. These results also indicate that
in various pathological conditions elicited by
endotoxin, the t-arg-NO pathway and ET peptides
are important endogenously occurring mediators.
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